Tech Company Financing Transactions
CellAegis Devices Funding Round
CellAegis Devices, operating out of Toronto ON, raised $9.5 million in funding from CTI Life Sciences Fund, Broadview Ventures and MaRS Investment Accelerator Fund.
Transaction Overview
Company Name
Announced On
3/15/2017
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Series C
Investors
CTI Life Sciences Fund (Lead Investor) (Shermaine Tilley)
Proceeds Purpose
This financing adds the experience of seasoned Canadian and U.S. medical technology investors, and demonstrates the support of our existing investors.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
139 Mulock Ave. 1st Floor
Toronto ON, M6N 1G9
Canada
Toronto ON, M6N 1G9
Canada
Phone
Website
Email Address
Overview
CellAegis Devices has patented and developed the non-invasive autoRIC Device, which delivers Remote Ischemic Conditioning (RIC) therapy to patients with acute and chronic cardiovascular conditions. This medical procedure protects the heart as well as other organs from ischemia and reperfusion injury.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rocky Ganske
Chief Financial Officer
Anne Raghurai
VP - Bus. Development
Vera Belaoussoff
Browse more venture capital transactions:
Prev: 3/15/2017: Evrything venture capital transaction
Next: 3/15/2017: StyleLend venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs